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The recent development and commercialization of Fuzeon (enfuvirtide) demonstrated that a
convergent strategy comprised of both solid- and solution-phase synthetic methodologies
presents a viable route for peptide manufacturing on a multi-ton scale. In this strategy, the
target sequence is prepared by stepwise solid-phase synthesis of protected peptide fragments,
which are then coupled together in the solution-phase to give the full-length sequence. These
synthetic methodologies pose a unique challenge for mass spectrometry (MS), as protected
peptide intermediates are often marked by poor solubility, structural lability, and low
ionization potential. Matrix-assisted laser desorption/ionization (MALDI) MS is uniquely
suited to such analytes; however, generalized protocols for MALDI analysis of protected
peptides have yet to be demonstrated. Herein, we report an operationally simple sample
preparation method for MALDI analysis of protected peptides, which greatly facilitates the
collection and interpretation of MS data. In this method, the difficulty in MS analysis of
protected peptides has been greatly diminished by use of dithranol as a matrix and CsCl as an
additive, giving rise to intentionally-formed Cs adducts. With greatly reduced fragmentation,
better crystalline morphology, and easier data interpretation, we anticipate that these findings
will find utility in peptide process development and manufacturing settings for reaction
monitoring, troubleshooting, and quality control. (J Am Soc Mass Spectrom 2008, 19, 614–619)
© 2008 American Society for Mass SpectrometryChemical synthesis is now a proven method forpeptide manufacturing on a multi-ton scale,having recently been demonstrated by Fuzeon
(enfuvirtide), a 36 amino acid residue peptide HIV
fusion inhibitor [1, 2]. The convergent synthetic strategy
developed for this process employs a two-step combi-
nation of solid- and solution-phase methodologies. In
the first step, solid-phase synthesis is used to prepare
the three side-chain-protected fragments (1-16, 17-26,
and 27-36), which encompass the full-length 36 amino
acid residue sequence. In the second step, these frag-
ments are joined in the solution phase to afford the
full-length sequence, which is then deprotected to fur-
nish the final active pharmaceutical ingredient (API).
As a result of its high yields and production efficiency,
this technology shows promise for a number of other
peptide-based compounds in pharmaceutical develop-
ment. These benefits notwithstanding, the unique phys-
icochemical characteristics of protected peptide inter-
mediates pose a challenge to high-resolution MS anal-
ysis, a critical step in analytical monitoring of synthetic
processes.
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doi:10.1016/j.jasms.2008.01.010In most cases, the majority—if not all—of the com-
mon proteinogenic functional groups are masked dur-
ing peptide synthesis so that they will not interfere with
iterative coupling and deprotection procedures. While
indispensable from a synthetic perspective, these pro-
tecting groups (e.g., Fmoc, Boc, tBu, Trt, Pbf) present
multiple problems from an analytical perspective. First,
protection of reactive functional groups results in abro-
gation of their ionization potential, rendering MS anal-
ysis under mild conditions difficult, if at all possible.
Moreover, protected peptides are often only sparingly
soluble, and in many cases require aggressive solvents
(e.g., fluorinated alcohols, DMSO, DMF) for dissolution,
which are incompatible with many MS methods. Fi-
nally, even if ionization is accomplished, this is usually
accompanied by significant source-induced fragmenta-
tion, usually at protected functional groups, with the
net result of artifactually “impure” MS data incongru-
ous with the purity of the actual sample.
Among MS methods, MALDI-TOF instruments are
uniquely suited to the analysis of protected peptides for
several inter-related reasons. Since ionization occurs
directly from a solid, dry phase, the MALDI source is
ideal for analytes of limited solubility in aqueous buffer
systems such as those commonly employed in ESI-
equipped instruments. Moreover, time-of-flight (TOF)
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of intact side-chain protecting groups, will acquire only
a single charge; most ion trap or quadrupole mass
analyzers have am/z range limited at 2000–3000 and are
therefore of limited utility in detection of singly-
charged ions of 3000 Da. Finally, MALDI is one of the
most tolerant MS techniques with respect to salts and
solvents, principally due to its extreme (i.e., femtomole)
sensitivity, which allows virtually any analyte solution
to be diluted extensively such that contaminant concen-
trations are reduced to the sub-millimolar level [3].
MALDI sample preparation has been optimized for
MS analysis of analytes with unique physicochemical
properties; notable examples include polymers [4],
phosphopeptides [5], low abundance proteins [6, 7],
and oligonucleotides [8, 9]. However, it has not, to our
knowledge, been optimized for the analysis of pro-
tected peptides. While this class of compounds was
formerly of limited importance, MS analysis of pro-
tected peptide intermediates in process development
and manufacturing environments has been given new
impetus as a result of the recent “renaissance” in conver-
gent peptide synthesis methods for active pharmaceu-
tical ingredient API manufacturing. In the work de-
scribed herein, we describe the rational optimization,
using both empirical and physicochemical criteria, of
MALDI sample preparation to provide a generally appli-
cable and operationally simple protocol for in-process
analysis of protected peptide synthetic intermediates.
Experimental
Materials and Reagents
Fuzeon fragments (FF) 1, 2, and 3 were obtained from
Roche Colorado Corporation Manufacturing (Boulder,
CO) as in-process sample retains. Fragment sequences
and masses are as follows: FF1, Ac-Tyr(tBu)-Thr(tBu)-
Ser(tBu)-Leu-Ile-His(Trt)-Ser(tBu)-Leu-Ile-Glu(OtBu)-
Glu(OtBu)-Ser(tBu)-Gln(Trt)-Asn(Trt)-Gln(Trt)-Gln-OH,
MW (monoisotopic) 3291.80, (average) 3294.05; FF2,
Fmoc-Glu(OtBu)-Lys(Boc)-Asn(Trt)-Glu(OtBu)-Gln(Trt)-
Glu(OtBu)-Leu-Leu-Glu(OtBu)-Leu-OH, MW (monoiso-
topic) 2274.22, (average) 2275.76; FF3, H2N-Asp(OtBu)-
Lys(Boc)-Trp(Boc)-Ala-Ser(tBu)-Leu-Trp(Boc)-Asn(Trt)-
Trp(Boc)-Phe-CONH2, MW (monoisotopic) 2105.10,
(average) 2106.50. Milli-Q water was used in all prepa-
rations. Acetonitrile (ACN) and N,N-dimethylform-
amide (DMF) were from Mallinkrodt Baker (Phillips-
burg, NJ). Matrix compounds and inorganic salts were
obtained from Sigma Aldrich (St. Louis, MO) and used
without further purification.
General Procedures for MALDI Sample
Preparation
For all experiments, peptide fragments were first dis-
solved to a concentration of 10 mg/mL (wt/vol) in
DMF; these stock solutions were then diluted 100-foldinto matrix solutions except where otherwise noted.
Matrix solutions were prepared as saturated solutions
and used within 1 day. When salts were used in sample
preparations, a stock solution was prepared at 100
mg/mL (wt/vol) in water and diluted 10-fold into the
appropriate matrix solution to give a final matrix/salt
solution which was saturated with respect to matrix
and 10 mg/mL (wt/vol) with respect to salt.
Optimized Sample Preparation for Protected
Peptides
The protected peptide to be analyzed is dissolved in
DMF to a concentration of 10 mg/mL (wt/vol). A
matrix stock solution is prepared by dissolving dithra-
nol (CAS# 1143-38-0) into ACN:water (1:1, vol/vol).
CsCl is then prepared as a separate stock solution at 100
mg/mL (wt/vol) in water and diluted 10-fold into the
matrix solution. For sample analysis, the peptide solu-
tion is diluted 100-fold into the CsCl/dithranol solution
and vortexed briefly; 1 L of this solution is then
aliquoted onto a stainless steel target plate and allowed
to dry at ambient temperature and pressure before
MALDI sample analysis.
MALDI Sample Analysis
MALDI mass spectra were collected using a Bruker
Microflex LRF MALDI mass spectrometer (Bruker Dal-
tonics, Billerica, MA). Samples were analyzed in the
linear positive ion mode, with 500 laser shots collected
at random across each sample spot and summed using
the automated sample collection mode. All spectra were
processed by Savitzky-Golay smoothing and baseline
subtraction.
Results and Discussion
Before the start of this work, it was apparent that
conventional sample preparations for MALDI analysis
of protected peptides left much to be desired. Mass
spectra were difficult to collect and interpret due to
poor sample spot morphology and sluggish ionization,
and were usually accompanied by significant fragmen-
tation. In the protected peptides under analysis the net
result was that it was difficult to distinguish between
bona fide synthetic (notably des-trityl and des-tBu) impu-
rities and artifactual, source-induced fragmentation in
the mass spectrometer.
We first reasoned that a screen of different matrices
might uncover one more effective for the protected
peptides under investigation. For instance, it is well
known that sinapinic acid (SA) [10] is more suitable for
large proteins than -cyano-4-hydroxycinnamic acid
(4HCA) [11] or 2,5-dihydroxybenzoic acid (DHB) [12],
and basic or charge-neutral matrices are more appro-
priate for oligonucleotide analysis [9, 13]. This latter
point was especially noteworthy; it seemed reasonable
616 SCHAIBERGER AND MOSS J Am Soc Mass Spectrom 2008, 19, 614–619that if the fragmentation of protected peptides using
classical peptide/protein MALDI matrices was due to
the acidity of the matrix compound, then a less-acidic
matrix would address this chemical incompatibility just
as is the case for acid-labile oligonucleotides. In addi-
tion, the physicochemical similarity of protected pep-
tides to hydrophobic polymers led us to consider that
2-(4-hydroxyphenylazo)benzoic acid (HABA) [14, 15],
pyrene, or anthracene [16] might be appropriate for
their analysis as well, just as these matrices have been
reported to be useful for MS analysis of polymers. It
should be emphasized, however, that the functional
groups commonly present in peptides (even with protect-
ing groups intact) impose a further complication over
relatively nonfunctionalized polymers such as polysty-
rene, polyisoprene, and polybutadiene. As a result,
all-trans-retinoic acid (RTA) and trans-3-indoleacrylic
acid (IAA) [16]—two matrices also commonly used in
MS analysis of polymers—were excluded from the
present study owing to the reactivity of these matrices
Figure 1. MALDI mass spectra of FF1 (a), FF2 (
Table 1. Summary of MALDI matrix compounds screened in
FF1 analysis
Matrix Resultsa
-Cyano-4-hydroxycinnamic acid (HCA) 
2,5-Dihydroxybenzoic acid (DHB) 
Sinapinic acid (SA) 
2-(4-Hydroxyphenylazo)benzoic acid (HABA) 
Dithranol 
2-Amino-4-methyl-3-nitropyridine (3-ANP) 
2-Amino-4-methyl-5-nitropyridine (5-ANP) 
Pyrene 
Anthracene 
aKey: () no signal obtained, () some signal obtained, with significant
fragmentation, () strong molecular ion signal obtained, with little
fragmentation.matrices. Asterisks denote molecular ions or Na/Ktoward proteinaceous amine and thiol functionalities
via conjugate addition reactions.
Our initial matrix screen was performed using FF1
(see Experimental section for structures) as a test ana-
lyte. The matrices selected in this study were chosen
based on both historical success and electronic proper-
ties. HCA, SA, and DHB are the most widely-used
matrices for peptide and protein analysis (vide supra),
although DHB has found some application in polymer
analysis [17]. HABA, pyrene, anthracene, and dithranol
[18] were selected based on their well-known applica-
bility in polymer analysis. It is noteworthy that pyrene
and anthracene were also of interest due to their charge-
neutral character, toward the end of investigating
whether partial deprotection in MALDI analysis is due
to acidic deprotection by carboxy-functionalized matri-
ces. 2-Amino-4-methyl-3-nitropyridine (3-ANP) and
2-amino-4-methyl-5-nitropyridine (5-ANP) were also
investigated, owing to their demonstrated utility in
oligonucleotide analysis [9]. The FF1 analyte was se-
lected for this screen because it represents a typical
“real world” protected peptide; it has no basic func-
tional groups, is of a reasonable size (16 amino acid
residues), and is known to undergo variable degrees of
detritylation at the His-1 side-chain during MALDI
analysis (vide infra), though it is unclear whether this
fragmentation occurs during sample preparation, ion-
ization, or mass analysis.
To closely mimic a typical production sampling, a
stock solution of FF1 was prepared in DMF and diluted
100-fold into matrix solutions, all prepared as saturated
solutions in ACN:water (1:1, vol/vol). It should be
emphasized that nonvolatile solvents are commonly
known to be deleterious for MS analysis, and in the case
of MALDI might lead to poorly-formed crystals on the
sample target. Nonetheless, this sample preparation
d FF3 (c) using HCA (red) and dithranol (blue)b), an
 adducts.
vent
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provide a robust method useful in a typical production
setting, wherein DMF is a near-generally applicable
solvent for protected peptides. From the results of this
initial matrix screen, it was clear that these matrices
could be classified into three categories, with (1) no
signal obtained, (2) some signal obtained, albeit with
extensive fragmentation, or (3) the molecular ion was
the predominant signal obtained, with little fragmenta-
tion. By far the most efficacious matrix was dithranol,
which consistently afforded the easiest to obtain signals
and the least fragmentation (Table 1). In most other
cases—HCA, DHB, and HABA excepted—virtually no
signal was obtained, and with HCA and DHB, signifi-
cant fragmentation was observed.
To determine if dithranol would afford improved
signal quality for more than one protected peptide
analyte, MALDI spectra were obtained on Fuzeon frag-
ments 1, 2, and 3 (FF1, FF2, and FF3) using dithranol
and HCA as matrices. In all cases, dithranol provided
significantly less source-induced fragmentation, despite
the need for higher laser intensity to effect ionization
(Figure 1). It is noteworthy that the signal-to-noise ratio
of the molecular ions is comparable for dithranol and
HCA, thus minimization of fragmentation is not accom-
panied by a loss in overall ionization intensity. One
possible explanation for this difference is the signifi-
cantly decreased acidity of dithranol (pKa  7.16 
Figure 2. (a) Stacked MALDI mass spectra of F
with 10 mg/mL salt additives. (b) Expanded r
multiple cationized salt adducts arising from ad0.20) compared with HCA (pKa  1.17  0.31) [19].However, the well-known empirical nature of matrix
performance, as well as the failure of the basic (3-ANP
and 5-ANP) and uncharged (pyrene and anthracene)
matrices underscore the point that other contributory
factors are determinative of matrix performance in
protected peptide analysis.
While the practical benefits of dithranol as a matrix
in MALDI analysis of these protected peptides are clear,
two outstanding issues motivated further optimization
of this method. First, in many cases the crystalline
morphology of the dried sample spots on the MALDI
target is highly heterogeneous, thereby complicating
automated sample collection; this is an important con-
sideration in a high-throughput analytical support lab-
oratory, wherein manual laser “navigation” is not a
viable option. Second, interpretation of these spectra is
occasionally difficult and requires knowledge of the
various commonly-observed salt adducts obtained in
MALDI. Toward the end of providing a generalized
protocol accessible to the non-specialist, we sought to
simplify this microheterogeneity to yield more easily-
interpreted spectra.
The addition of salts has been reported to aid in
MALDI analysis of polymers devoid of functional
groups by facilitating ionization under mild conditions
[16, 17]. A priori, this was a reasonable expedient to
apply in the present application; synthetic peptides are
in many cases homologous to hydrophobic polymers
repared from a dithranol matrix without salt or
of salt-free and CsCl-doped samples showing
itious salt contamination.F1, p
egionwith few, if any, “handles” for ionization, and are
618 SCHAIBERGER AND MOSS J Am Soc Mass Spectrom 2008, 19, 614–619marked by similar solubility profiles. We first at-
tempted to use transition-metal salts derived from AgI
and CuII, but these quickly proved totally ineffective,
and in fact nearly abolished ionization (data not
shown). Moreover, the spectra obtained were domi-
nated by unidentified low molecular weight species,
likely either salt/matrix clusters or oxidatively decom-
posed samples (a likely possibility given that these metal
salts are commonly used oxidants in peptide chemistry).
We therefore considered that given the ease with which
analytes, notably protected peptides, ionize as Na or
K adducts, nonreactive alkali salts could prove effica-
cious as additives in the matrix solution. A screen of
LiCl, NaCl, KCl, and CsCl (added to the matrix solution
at 10 mg/mL) was therefore performed using FF1 as a
test analyte, with all four salts yielding the expected
cation adduct as the predominant singly-charged ion
species (Figure 2a).
Two important observations were made from this
experiment. First, the usual presence of multiple (typi-
cally ca. 5) cationized salt adducts is minimized through
these intentional salt additions. As a result, spectra are
much simpler to interpret, with automated peak pick-
ing algorithms identifying a single major species with
an easily-assignable identity. It is noteworthy that in all
salt additions, a singly-charged double-cation adduct
was observed as a minor species. This is presumably the
charge-neutral C-terminal carboxylate salt, and is most
apparent in samples analyzed with added CsCl. Sec-
ond, the crystalline morphology of these samples on the
MALDI target is significantly more homogeneous than
without salt additions, which is likely due to the crys-
tallization of added salts during sample spot evapora-
tion. However, it is unclear whether these crystals are
essentially the parent salts crystals interspersed within
a dried peptide film, or rather a co-crystal lattice com-
posed of matrix, analyte, and the exogenous salt addi-
tive. Whereas automated sample collection software
was problematic in the case where the spot surface was
marked by a few large monoliths or a film with most
analyte on the outside rim, the addition of some of these
salts results in an evenly “peppered” sample surface
that allows for easy data acquisition.
Of the four salt additives, CsCl is the preferred
additive for several reasons. Whereas Na and K
adducts are commonly found in comparable abundance
due to trace amounts of these elements in solvents and
glassware, Cs (132.9) adducts are entirely due to
intentional doping of the sample being analyzed. As a
result, the correct Cs adduct can be unambiguously
identified with high confidence and without manual
intervention, a key consideration in high throughput
quality control laboratory settings (Figure 2b). Another
noteworthy observation is the salt-dependent varia-
tion in crystalline morphology of the sample spot on
the MALDI target surface. LiCl resulted in a glassy
surface with few noticeable crystals, while NaCl gave
large crystals where analyte was concentrated, with
little signal obtained elsewhere on the target surface.In contrast, KCl and CsCl produced homogeneous
spot surfaces with even analyte distributions. For these
reasons—vastly reduced heterogeneity in cationized
salt adducts and homogeneous crystalline morphology
on the sample target—CsCl is the preferred additive for
protected peptide analysis by MALDI.
In a typical manufacturing setting, sample quantities
are not limiting as is the case in proteomics applica-
tions; a sample peptide concentration of 10 mg/mL is
therefore a reasonable concentration for sample solu-
tions. However, protected peptides are often marked by
gross insolubility, and within a research setting it can
often be expected that sample quantities will be far
more limiting than on a manufacturing scale. Consid-
ering that salt additions are commonly acknowledged
to give rise to signal suppression in MS analysis [20–
22], we performed a sensitivity study to investigate
whether the addition of CsCl to samples would have a
detrimental effect on sensitivity. For this experiment,
the FF1 stock solution was serially diluted in 10-fold
increments to 1.0, 0.1, 0.01, and 0.001 mg/mL before
100-fold dilution into dithranol or dithranol/CsCl solu-
tions. Even at the 1 g/mL starting concentration, the
same improvement in signal quality is discernable, with
only 3 fmol analyte aliquoted onto the MALDI target
(Figure 3).
Figure 3. MALDI mass spectra of FF1 using dithranol (red) and
dithranol/CsCl (blue) matrices at 10,000-fold dilution of original
peptide stock solution, with each sample spot containing 3 fmol
analyte.
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MS analysis of protected peptides is an analytical chal-
lenge for several interrelated reasons. With all functional
groups masked by hydrophobic protecting groups, this
class of compounds is often sparingly soluble, requiring
the use of solvents not commonly associated with
sample preparation for MS analysis. The chemical labil-
ity of these functional groups imposes an additional
complication, as source-induced fragmentation can be
difficult to discern from genuine sample impurities. The
intrinsic difficulty in MS analysis of non-ionizable com-
pounds is a further obstacle to obtaining clean, easily
interpreted mass spectra. In this report, dithranol has
been shown to be an optimal matrix for three “real
world” protected peptide samples, producing signifi-
cantly less fragmentation in collected mass spectra. The
addition of CsCl to the dithranol matrix solution is a
further improvement, resulting in improved crystalline
morphology on the MALDI sample target, as well as
easily-interpreted mass spectra through the generation
of unambiguous Cs adducts, all without detriment to
sensitivity. We envisage that these tactics will find use
among investigators in process development and man-
ufacturing settings, where facile, high-resolution MS
analysis of protected peptide intermediates is a concern
of primary importance.
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